Capecitabine

Category API

Details	Specifications
CAS Number	154361-50-9
Molecular Formula	C15H22FN3O6
Molecular Weight	359.35 g/mol.
Synonyms	5'-Deoxy-5-fluoro-N4-[(pentyloxy)carbonyl]cytidine
Chemical Name	5'-deoxy-5-fluoro[(pentyloxy)carbonyl] cytidine.
Common name	Capecitabine
Therapeutic use	Capecitabine is used to treat breast cancer, colon cancer or rectal cancer. Capecitabine is in a class of medications called antimetabolites. It works by stopping or slowing the growth of cancer cells.
Background	Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Grade	EP and USP
Polymorph	Not existed.
GTI	Risk assessment report available
Nitrosamines	Risk assessment report available
DMF Availability	USDMF# 24689, CEP 2014-332 - REV 03
Manufacturing batch size	350.0 kg
Production capacity	Annual capacity 48 – 50 tonnes
Stability data	Available

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Capecitabine are also Available for

Questions & Answers

FAQ on Capecitabine

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.